NEW YORK, Nov. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits can be filed on behalf of shareholders of Bed Bath & Beyond, Inc. ( NASDAQ: BBBY ), Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT) and Palantir Technologies, Inc. (NYSE: PLTR). Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.
Bed Bath & Beyond, Inc. (NASDAQ:BBBY)
Class Period: March 25, 2022 – August 18, 2022
Lead Plaintiff Deadline: November 7, 2022
On March 6, 2022, Ryan Cohen, the billionaire co-founder of Chewy Inc., who also served as chairman of GameStop Corp. , through his investment firm RC Ventures LLC, wrote a letter to the Board of Directors of Bed Bath & Beyond announcing that he owned a 9.8% interest in Bed Bath & Beyond and criticizing the company’s management .
As a result of this news, Bed Bath & Beyond stock closed 34% higher on March 7, 2022 than on March 4, 2022, the previous trading day, on extremely high trading volume.
On March 25, 2022, Bed Bath & Beyond added three new directors appointed by Ryan Cohen’s investment firm RC Ventures LLC.
On August 15, 2022, Ryan Cohen, through his investment firm RC Ventures LLC, announced in a SEC filing that it had purchased over a million January 2023 call options with strike prices of $60, $75, and $80 — significantly higher than Bed Bath’s stock & Beyond acted.
As a result of this news, Bed Bath & Beyond stock closed 29% higher on August 16, 2022 compared to its closing price on August 15, 2022 due to extremely high trading volume.
Then, on August 18, 2022, Ryan Cohen, through his investment firm RC Ventures LLC, announced that he was selling his entire interest in Bed Bath & Beyond. Also on August 18, 2022, Bloomberg published an article entitled “Bed Bath & Beyond Taps Kirkland & Ellis for…
Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/11/07/2549212/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-Bed-Bath-Beyond-Sema4-Medtronic-and-Palantir-and-Encourages-Investors-to-Contact-the-Fi.html